University, Subject, Country, Region, World

Regeneron Pharmaceuticals Inc Scientists Rankings 2024

H-Index Rankings
University / Institution:
# 1
Country:
# 1,230
Region:
# 1,323
World:
# 2,655
H-Index
Total:
133
Last 6 Year:
88
Last 6 Year/Total:
0.662
i10 Index
Total:
447
Last 6 Year:
306
Last 6 Year/Total:
0.685
Citation
Total:
136,687
Last 6 Year:
57,650
Last 6 Year/Total:
0.422
Jeffrey Reid
Genome Informatics
Data Engineering
Bioinformatics
Computational Biology
Genomics
H-Index Rankings
University / Institution:
# 2
Country:
# 1,650
Region:
# 1,771
World:
# 3,558
H-Index
Total:
124
Last 6 Year:
78
Last 6 Year/Total:
0.629
i10 Index
Total:
257
Last 6 Year:
188
Last 6 Year/Total:
0.732
Citation
Total:
128,088
Last 6 Year:
52,600
Last 6 Year/Total:
0.411
Jonathan Marchini
Statistical Genetics
Population Genetics
High-Dimensional Data Analysis
Bayesian Statistics
Genome-wide association studies
H-Index Rankings
University / Institution:
# 3
Country:
# 7,195
Region:
# 7,866
World:
# 16,081
H-Index
Total:
83
Last 6 Year:
73
Last 6 Year/Total:
0.880
i10 Index
Total:
129
Last 6 Year:
115
Last 6 Year/Total:
0.891
Citation
Total:
125,103
Last 6 Year:
52,020
Last 6 Year/Total:
0.416
David Glass
aging
skeletal muscle
experimental design
reproducibility
history of science
H-Index Rankings
University / Institution:
# 4
Country:
# 7,256
Region:
# 7,936
World:
# 16,261
H-Index
Total:
83
Last 6 Year:
55
Last 6 Year/Total:
0.663
i10 Index
Total:
164
Last 6 Year:
136
Last 6 Year/Total:
0.829
Citation
Total:
42,686
Last 6 Year:
13,321
Last 6 Year/Total:
0.312
H-Index Rankings
University / Institution:
# 5
Country:
# 9,544
Region:
# 10,498
World:
# 21,955
H-Index
Total:
76
Last 6 Year:
51
Last 6 Year/Total:
0.671
i10 Index
Total:
136
Last 6 Year:
119
Last 6 Year/Total:
0.875
Citation
Total:
21,868
Last 6 Year:
8,354
Last 6 Year/Total:
0.382
H-Index Rankings
University / Institution:
# 6
Country:
# 13,198
Region:
# 14,600
World:
# 31,334
H-Index
Total:
68
Last 6 Year:
48
Last 6 Year/Total:
0.706
i10 Index
Total:
139
Last 6 Year:
121
Last 6 Year/Total:
0.871
Citation
Total:
21,191
Last 6 Year:
8,581
Last 6 Year/Total:
0.405
H-Index Rankings
University / Institution:
# 7
Country:
# 13,676
Region:
# 15,140
World:
# 32,549
H-Index
Total:
67
Last 6 Year:
51
Last 6 Year/Total:
0.761
i10 Index
Total:
155
Last 6 Year:
138
Last 6 Year/Total:
0.890
Citation
Total:
30,512
Last 6 Year:
20,312
Last 6 Year/Total:
0.666
H-Index Rankings
University / Institution:
# 8
Country:
# 16,821
Region:
# 18,678
World:
# 41,033
H-Index
Total:
62
Last 6 Year:
52
Last 6 Year/Total:
0.839
i10 Index
Total:
123
Last 6 Year:
100
Last 6 Year/Total:
0.813
Citation
Total:
59,131
Last 6 Year:
26,997
Last 6 Year/Total:
0.457
H-Index Rankings
University / Institution:
# 9
Country:
# 24,754
Region:
# 27,693
World:
# 63,627
H-Index
Total:
53
Last 6 Year:
51
Last 6 Year/Total:
0.962
i10 Index
Total:
107
Last 6 Year:
99
Last 6 Year/Total:
0.925
Citation
Total:
13,589
Last 6 Year:
12,501
Last 6 Year/Total:
0.920
Adam E Locke
Human and Statistical Genetics/Genomics
Sequencing
Down Syndrome
Obesity and Diabetes
H-Index Rankings
University / Institution:
# 10
Country:
# 28,270
Region:
# 31,708
World:
# 74,294
H-Index
Total:
50
Last 6 Year:
45
Last 6 Year/Total:
0.900
i10 Index
Total:
82
Last 6 Year:
80
Last 6 Year/Total:
0.976
Citation
Total:
23,270
Last 6 Year:
16,643
Last 6 Year/Total:
0.715
H-Index Rankings
University / Institution:
# 11
Country:
# 31,061
Region:
# 34,891
World:
# 83,240
H-Index
Total:
48
Last 6 Year:
38
Last 6 Year/Total:
0.792
i10 Index
Total:
79
Last 6 Year:
65
Last 6 Year/Total:
0.823
Citation
Total:
23,378
Last 6 Year:
7,884
Last 6 Year/Total:
0.337
H-Index Rankings
University / Institution:
# 12
Country:
# 37,094
Region:
# 41,760
World:
# 102,520
H-Index
Total:
44
Last 6 Year:
36
Last 6 Year/Total:
0.818
i10 Index
Total:
57
Last 6 Year:
52
Last 6 Year/Total:
0.912
Citation
Total:
109,434
Last 6 Year:
44,912
Last 6 Year/Total:
0.410
H-Index Rankings
University / Institution:
# 13
Country:
# 38,855
Region:
# 43,797
World:
# 108,469
H-Index
Total:
43
Last 6 Year:
34
Last 6 Year/Total:
0.791
i10 Index
Total:
60
Last 6 Year:
50
Last 6 Year/Total:
0.833
Citation
Total:
46,208
Last 6 Year:
18,774
Last 6 Year/Total:
0.406
Neelroop Parikshak
Neuroscience
Neurology
Genomics
Computational Biology
Gene Regulatory Networks
H-Index Rankings
University / Institution:
# 14
Country:
# 56,448
Region:
# 63,808
World:
# 169,548
H-Index
Total:
35
Last 6 Year:
29
Last 6 Year/Total:
0.829
i10 Index
Total:
37
Last 6 Year:
36
Last 6 Year/Total:
0.973
Citation
Total:
12,330
Last 6 Year:
6,811
Last 6 Year/Total:
0.552
H-Index Rankings
University / Institution:
# 15
Country:
# 60,550
Region:
# 68,516
World:
# 184,817
H-Index
Total:
34
Last 6 Year:
21
Last 6 Year/Total:
0.618
i10 Index
Total:
52
Last 6 Year:
30
Last 6 Year/Total:
0.577
Citation
Total:
3,903
Last 6 Year:
1,440
Last 6 Year/Total:
0.369
H-Index Rankings
University / Institution:
# 16
Country:
# 61,913
Region:
# 70,036
World:
# 189,394
H-Index
Total:
33
Last 6 Year:
29
Last 6 Year/Total:
0.879
i10 Index
Total:
58
Last 6 Year:
55
Last 6 Year/Total:
0.948
Citation
Total:
15,243
Last 6 Year:
14,505
Last 6 Year/Total:
0.952
John D Davis
clinical pharmacology
monoclonal antibodies
drug-drug interactions
pharmacokinetics/pharmacodynamics
H-Index Rankings
University / Institution:
# 17
Country:
# 63,070
Region:
# 71,381
World:
# 193,835
H-Index
Total:
33
Last 6 Year:
23
Last 6 Year/Total:
0.697
i10 Index
Total:
67
Last 6 Year:
40
Last 6 Year/Total:
0.597
Citation
Total:
7,040
Last 6 Year:
5,429
Last 6 Year/Total:
0.771
H-Index Rankings
University / Institution:
# 18
Country:
# 63,293
Region:
# 71,624
World:
# 194,626
H-Index
Total:
33
Last 6 Year:
22
Last 6 Year/Total:
0.667
i10 Index
Total:
71
Last 6 Year:
43
Last 6 Year/Total:
0.606
Citation
Total:
3,180
Last 6 Year:
1,596
Last 6 Year/Total:
0.502
H-Index Rankings
University / Institution:
# 19
Country:
# 63,370
Region:
# 71,710
World:
# 194,919
H-Index
Total:
33
Last 6 Year:
22
Last 6 Year/Total:
0.667
i10 Index
Total:
55
Last 6 Year:
37
Last 6 Year/Total:
0.673
Citation
Total:
8,539
Last 6 Year:
4,602
Last 6 Year/Total:
0.539
H-Index Rankings
University / Institution:
# 20
Country:
# 66,093
Region:
# 74,768
World:
# 204,495
H-Index
Total:
32
Last 6 Year:
24
Last 6 Year/Total:
0.750
i10 Index
Total:
59
Last 6 Year:
40
Last 6 Year/Total:
0.678
Citation
Total:
2,923
Last 6 Year:
1,568
Last 6 Year/Total:
0.536
Ashique Rafique
biochemistry
biotherapeutic
biotechnology
biophyiscs
cancer immunology
H-Index Rankings
University / Institution:
# 21
Country:
# 75,661
Region:
# 85,638
World:
# 240,313
H-Index
Total:
29
Last 6 Year:
27
Last 6 Year/Total:
0.931
i10 Index
Total:
47
Last 6 Year:
42
Last 6 Year/Total:
0.894
Citation
Total:
7,769
Last 6 Year:
6,042
Last 6 Year/Total:
0.778
H-Index Rankings
University / Institution:
# 22
Country:
# 77,579
Region:
# 87,827
World:
# 248,077
H-Index
Total:
29
Last 6 Year:
20
Last 6 Year/Total:
0.690
i10 Index
Total:
56
Last 6 Year:
34
Last 6 Year/Total:
0.607
Citation
Total:
3,298
Last 6 Year:
1,502
Last 6 Year/Total:
0.455
H-Index Rankings
University / Institution:
# 23
Country:
# 81,169
Region:
# 91,898
World:
# 261,704
H-Index
Total:
28
Last 6 Year:
21
Last 6 Year/Total:
0.750
i10 Index
Total:
56
Last 6 Year:
40
Last 6 Year/Total:
0.714
Citation
Total:
2,448
Last 6 Year:
1,322
Last 6 Year/Total:
0.540
H-Index Rankings
University / Institution:
# 24
Country:
# 83,081
Region:
# 94,053
World:
# 269,268
H-Index
Total:
28
Last 6 Year:
14
Last 6 Year/Total:
0.500
i10 Index
Total:
42
Last 6 Year:
17
Last 6 Year/Total:
0.405
Citation
Total:
2,939
Last 6 Year:
603
Last 6 Year/Total:
0.205
H-Index Rankings
University / Institution:
# 25
Country:
# 86,390
Region:
# 97,798
World:
# 282,117
H-Index
Total:
27
Last 6 Year:
18
Last 6 Year/Total:
0.667
i10 Index
Total:
52
Last 6 Year:
33
Last 6 Year/Total:
0.635
Citation
Total:
2,260
Last 6 Year:
1,106
Last 6 Year/Total:
0.489
H-Index Rankings
University / Institution:
# 26
Country:
# 88,303
Region:
# 99,954
World:
# 289,241
H-Index
Total:
26
Last 6 Year:
25
Last 6 Year/Total:
0.962
i10 Index
Total:
39
Last 6 Year:
37
Last 6 Year/Total:
0.949
Citation
Total:
10,218
Last 6 Year:
4,560
Last 6 Year/Total:
0.446
H-Index Rankings
University / Institution:
# 27
Country:
# 91,192
Region:
# 103,233
World:
# 300,574
H-Index
Total:
26
Last 6 Year:
18
Last 6 Year/Total:
0.692
i10 Index
Total:
33
Last 6 Year:
29
Last 6 Year/Total:
0.879
Citation
Total:
7,011
Last 6 Year:
3,253
Last 6 Year/Total:
0.464
H-Index Rankings
University / Institution:
# 28
Country:
# 94,005
Region:
# 106,405
World:
# 311,702
H-Index
Total:
25
Last 6 Year:
22
Last 6 Year/Total:
0.880
i10 Index
Total:
35
Last 6 Year:
30
Last 6 Year/Total:
0.857
Citation
Total:
5,181
Last 6 Year:
4,480
Last 6 Year/Total:
0.865
H-Index Rankings
University / Institution:
# 29
Country:
# 94,241
Region:
# 106,676
World:
# 312,637
H-Index
Total:
25
Last 6 Year:
21
Last 6 Year/Total:
0.840
i10 Index
Total:
48
Last 6 Year:
41
Last 6 Year/Total:
0.854
Citation
Total:
2,160
Last 6 Year:
1,688
Last 6 Year/Total:
0.781
Sai Kiran Sharma
Molecular Imaging
Antibody-based therapeutics
immunoPET
Targeted Radiotherapy
Cancer Biology
H-Index Rankings
University / Institution:
# 30
Country:
# 95,515
Region:
# 108,105
World:
# 317,548
H-Index
Total:
25
Last 6 Year:
19
Last 6 Year/Total:
0.760
i10 Index
Total:
36
Last 6 Year:
29
Last 6 Year/Total:
0.806
Citation
Total:
1,590
Last 6 Year:
1,181
Last 6 Year/Total:
0.743
H-Index Rankings
University / Institution:
# 31
Country:
# 98,307
Region:
# 111,292
World:
# 328,505
H-Index
Total:
24
Last 6 Year:
23
Last 6 Year/Total:
0.958
i10 Index
Total:
58
Last 6 Year:
48
Last 6 Year/Total:
0.828
Citation
Total:
1,852
Last 6 Year:
1,560
Last 6 Year/Total:
0.842
H-Index Rankings
University / Institution:
# 32
Country:
# 102,250
Region:
# 115,722
World:
# 344,077
H-Index
Total:
24
Last 6 Year:
16
Last 6 Year/Total:
0.667
i10 Index
Total:
31
Last 6 Year:
22
Last 6 Year/Total:
0.710
Citation
Total:
3,112
Last 6 Year:
1,238
Last 6 Year/Total:
0.398
H-Index Rankings
University / Institution:
# 33
Country:
# 103,214
Region:
# 116,811
World:
# 347,973
H-Index
Total:
24
Last 6 Year:
13
Last 6 Year/Total:
0.542
i10 Index
Total:
27
Last 6 Year:
17
Last 6 Year/Total:
0.630
Citation
Total:
2,747
Last 6 Year:
1,439
Last 6 Year/Total:
0.524
H-Index Rankings
University / Institution:
# 34
Country:
# 106,027
Region:
# 119,994
World:
# 358,959
H-Index
Total:
23
Last 6 Year:
19
Last 6 Year/Total:
0.826
i10 Index
Total:
34
Last 6 Year:
29
Last 6 Year/Total:
0.853
Citation
Total:
3,132
Last 6 Year:
1,740
Last 6 Year/Total:
0.556
Nidal Al-Huniti
Quantitative Clinical Pharmacology
Clinical Pharmacometrics
Statistics
Drug Development
Clinical
H-Index Rankings
University / Institution:
# 35
Country:
# 106,464
Region:
# 120,473
World:
# 360,713
H-Index
Total:
23
Last 6 Year:
18
Last 6 Year/Total:
0.783
i10 Index
Total:
42
Last 6 Year:
33
Last 6 Year/Total:
0.786
Citation
Total:
2,009
Last 6 Year:
1,289
Last 6 Year/Total:
0.642
Song Nie
Biotherapeutic Protein/AAV Characterization
LC-MS/MS
Bottom-Up Proteomics
Target Proteomics
H-Index Rankings
University / Institution:
# 36
Country:
# 106,941
Region:
# 121,005
World:
# 362,350
H-Index
Total:
23
Last 6 Year:
18
Last 6 Year/Total:
0.783
i10 Index
Total:
27
Last 6 Year:
23
Last 6 Year/Total:
0.852
Citation
Total:
2,600
Last 6 Year:
1,353
Last 6 Year/Total:
0.520
H-Index Rankings
University / Institution:
# 37
Country:
# 111,272
Region:
# 125,884
World:
# 379,663
H-Index
Total:
22
Last 6 Year:
20
Last 6 Year/Total:
0.909
i10 Index
Total:
28
Last 6 Year:
26
Last 6 Year/Total:
0.929
Citation
Total:
10,158
Last 6 Year:
6,192
Last 6 Year/Total:
0.610
Xuefei Zhong
Analytical Chemistry
LC-MS
CE-MS
Proteomics
Therapeutic protein
H-Index Rankings
University / Institution:
# 38
Country:
# 112,035
Region:
# 126,732
World:
# 382,388
H-Index
Total:
22
Last 6 Year:
19
Last 6 Year/Total:
0.864
i10 Index
Total:
29
Last 6 Year:
25
Last 6 Year/Total:
0.862
Citation
Total:
1,601
Last 6 Year:
895
Last 6 Year/Total:
0.559
Amrutesh S Puranik|Amrutesh S. Puranik
Cancer Vaccines
Immunotherapy
Fibrosis
Myleoid cells
Aging
Renal and Cardiovascular Diseases
Lupus nephritis
H-Index Rankings
University / Institution:
# 39
Country:
# 112,272
Region:
# 126,986
World:
# 382,969
H-Index
Total:
22
Last 6 Year:
19
Last 6 Year/Total:
0.864
i10 Index
Total:
23
Last 6 Year:
21
Last 6 Year/Total:
0.913
Citation
Total:
2,366
Last 6 Year:
1,880
Last 6 Year/Total:
0.795
H-Index Rankings
University / Institution:
# 40
Country:
# 113,998
Region:
# 128,926
World:
# 390,343
H-Index
Total:
22
Last 6 Year:
16
Last 6 Year/Total:
0.727
i10 Index
Total:
31
Last 6 Year:
18
Last 6 Year/Total:
0.581
Citation
Total:
1,560
Last 6 Year:
744
Last 6 Year/Total:
0.477
Fraser T Sparks
Neurobiology of learning and memory
context learning
coordinated neural processing
epilepsy
disease models
H-Index Rankings
University / Institution:
# 41
Country:
# 114,168
Region:
# 129,118
World:
# 390,843
H-Index
Total:
22
Last 6 Year:
16
Last 6 Year/Total:
0.727
i10 Index
Total:
27
Last 6 Year:
23
Last 6 Year/Total:
0.852
Citation
Total:
1,916
Last 6 Year:
1,270
Last 6 Year/Total:
0.663
H-Index Rankings
University / Institution:
# 42
Country:
# 116,690
Region:
# 131,956
World:
# 400,696
H-Index
Total:
21
Last 6 Year:
21
Last 6 Year/Total:
1.000
i10 Index
Total:
31
Last 6 Year:
29
Last 6 Year/Total:
0.935
Citation
Total:
2,637
Last 6 Year:
1,681
Last 6 Year/Total:
0.637
Mintai Peter Hwang
Formulation Development
Process Development
Immunotherapeutics
Controlled Delivery
H-Index Rankings
University / Institution:
# 43
Country:
# 118,981
Region:
# 134,501
World:
# 409,332
H-Index
Total:
21
Last 6 Year:
18
Last 6 Year/Total:
0.857
i10 Index
Total:
30
Last 6 Year:
25
Last 6 Year/Total:
0.833
Citation
Total:
1,352
Last 6 Year:
860
Last 6 Year/Total:
0.636
H-Index Rankings
University / Institution:
# 44
Country:
# 119,634
Region:
# 135,232
World:
# 411,966
H-Index
Total:
21
Last 6 Year:
17
Last 6 Year/Total:
0.810
i10 Index
Total:
33
Last 6 Year:
22
Last 6 Year/Total:
0.667
Citation
Total:
2,211
Last 6 Year:
1,454
Last 6 Year/Total:
0.658
H-Index Rankings
University / Institution:
# 45
Country:
# 119,717
Region:
# 135,329
World:
# 412,367
H-Index
Total:
21
Last 6 Year:
17
Last 6 Year/Total:
0.810
i10 Index
Total:
31
Last 6 Year:
23
Last 6 Year/Total:
0.742
Citation
Total:
2,497
Last 6 Year:
1,695
Last 6 Year/Total:
0.679
H-Index Rankings
University / Institution:
# 46
Country:
# 120,077
Region:
# 135,733
World:
# 413,543
H-Index
Total:
21
Last 6 Year:
17
Last 6 Year/Total:
0.810
i10 Index
Total:
25
Last 6 Year:
19
Last 6 Year/Total:
0.760
Citation
Total:
4,911
Last 6 Year:
2,509
Last 6 Year/Total:
0.511
Alireza Nomani
LNP
Antibody-Drug Conjugates
mAb Formulation
qMRI
H-Index Rankings
University / Institution:
# 47
Country:
# 121,324
Region:
# 137,156
World:
# 419,038
H-Index
Total:
21
Last 6 Year:
15
Last 6 Year/Total:
0.714
i10 Index
Total:
28
Last 6 Year:
22
Last 6 Year/Total:
0.786
Citation
Total:
1,551
Last 6 Year:
994
Last 6 Year/Total:
0.641
Susannah Brydges
CRISPR
cas9
genome editing
genome engineering
targeted protein degradation
H-Index Rankings
University / Institution:
# 48
Country:
# 121,496
Region:
# 137,353
World:
# 419,527
H-Index
Total:
21
Last 6 Year:
15
Last 6 Year/Total:
0.714
i10 Index
Total:
24
Last 6 Year:
18
Last 6 Year/Total:
0.750
Citation
Total:
2,021
Last 6 Year:
1,033
Last 6 Year/Total:
0.511
H-Index Rankings
University / Institution:
# 49
Country:
# 122,813
Region:
# 138,843
World:
# 425,305
H-Index
Total:
21
Last 6 Year:
12
Last 6 Year/Total:
0.571
i10 Index
Total:
25
Last 6 Year:
16
Last 6 Year/Total:
0.640
Citation
Total:
2,568
Last 6 Year:
640
Last 6 Year/Total:
0.249
H-Index Rankings
University / Institution:
# 50
Country:
# 123,061
Region:
# 139,108
World:
# 426,286
H-Index
Total:
21
Last 6 Year:
11
Last 6 Year/Total:
0.524
i10 Index
Total:
27
Last 6 Year:
12
Last 6 Year/Total:
0.444
Citation
Total:
1,987
Last 6 Year:
1,015
Last 6 Year/Total:
0.511
AD Scientific Index - World Scientists Rankings - 2024 H INDEX i10 INDEX CITATION
University / Institution Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
1 1,230 1,323 2,655
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc

133 88 0.662 447 306 0.685 136,687 57,650 0.422
2 1,650 1,771 3,558
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Molecular Biology & Genetics

Genome Informatics | Data Engineering | Bioinformatics | Computational Biology | Genomics |

124 78 0.629 257 188 0.732 128,088 52,600 0.411
3 7,195 7,866 16,081
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Mathematical Sciences

Statistical Genetics | Population Genetics | High-Dimensional Data Analysis | Bayesian Statistics | Genome-wide association studies |

83 73 0.880 129 115 0.891 125,103 52,020 0.416
4 7,256 7,936 16,261
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc History, Philosophy, Theology / History

aging | skeletal muscle | experimental design | reproducibility | history of science |

83 55 0.663 164 136 0.829 42,686 13,321 0.312
5 9,544 10,498 21,955
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Psychiatry

pain and itch | neurodegenerative disease | osteoarthritis | TRPV4 | KCC2 |

76 51 0.671 136 119 0.875 21,868 8,354 0.382
6 13,198 14,600 31,334
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Medical Genetics

bone biology | human genetics | rare diseases | protein engineering |

68 48 0.706 139 121 0.871 21,191 8,581 0.405
7 13,676 15,140 32,549
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Respiratory drug development | clinical trials |

67 51 0.761 155 138 0.890 30,512 20,312 0.666
8 16,821 18,678 41,033
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Asthma | genetics |

62 52 0.839 123 100 0.813 59,131 26,997 0.457
9 24,754 27,693 63,627
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

biotechnology | genetics | clinical trials |

53 51 0.962 107 99 0.925 13,589 12,501 0.920
10 28,270 31,708 74,294
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Molecular Biology & Genetics

Human and Statistical Genetics/Genomics | Sequencing | Down Syndrome | Obesity and Diabetes |

50 45 0.900 82 80 0.976 23,270 16,643 0.715
Adscientificindex

Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages

11 31,061 34,891 83,240
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

48 38 0.792 79 65 0.823 23,378 7,884 0.337
12 37,094 41,760 102,520
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Molecular Biology & Genetics

Bioinformatics and Genomics |

44 36 0.818 57 52 0.912 109,434 44,912 0.410
13 38,855 43,797 108,469
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Molecular Biology & Genetics

Bioinformatics | genomics | structural biology |

43 34 0.791 60 50 0.833 46,208 18,774 0.406
14 56,448 63,808 169,548
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Neuroscience

Neuroscience | Neurology | Genomics | Computational Biology | Gene Regulatory Networks |

35 29 0.829 37 36 0.973 12,330 6,811 0.552
15 60,550 68,516 184,817
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

34 21 0.618 52 30 0.577 3,903 1,440 0.369
16 61,913 70,036 189,394
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

33 29 0.879 58 55 0.948 15,243 14,505 0.952
17 63,070 71,381 193,835
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

clinical pharmacology | monoclonal antibodies | drug-drug interactions | pharmacokinetics/pharmacodynamics |

33 23 0.697 67 40 0.597 7,040 5,429 0.771
18 63,293 71,624 194,626
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

HEOR |

33 22 0.667 71 43 0.606 3,180 1,596 0.502
19 63,370 71,710 194,919
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Immunology

allergy | immunology | rheumatology |

33 22 0.667 55 37 0.673 8,539 4,602 0.539
20 66,093 74,768 204,495
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Cardiology

cardiology HEOR |

32 24 0.750 59 40 0.678 2,923 1,568 0.536
21 75,661 85,638 240,313
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Biochemistry

biochemistry | biotherapeutic | biotechnology | biophyiscs | cancer immunology |

29 27 0.931 47 42 0.894 7,769 6,042 0.778
22 77,579 87,827 248,077
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Endocrinology and Metabolism

endocrinology |

29 20 0.690 56 34 0.607 3,298 1,502 0.455
23 81,169 91,898 261,704
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc

28 21 0.750 56 40 0.714 2,448 1,322 0.540
24 83,081 94,053 269,268
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

28 14 0.500 42 17 0.405 2,939 603 0.205
25 86,390 97,798 282,117
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Economics & Econometrics / Economics

Health Economics and Outcomes Research |

27 18 0.667 52 33 0.635 2,260 1,106 0.489
26 88,303 99,954 289,241
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Molecular Biology & Genetics

Genomics | Statistical Genetics |

26 25 0.962 39 37 0.949 10,218 4,560 0.446
27 91,192 103,233 300,574
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Biological Science

Protein biochemistry | Structural Biology | Drug Discovery |

26 18 0.692 33 29 0.879 7,011 3,253 0.464
28 94,005 106,405 311,702
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

25 22 0.880 35 30 0.857 5,181 4,480 0.865
29 94,241 106,676 312,637
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

asthma | urticaria | pediatrics | nasal polyps | food allergy |

25 21 0.840 48 41 0.854 2,160 1,688 0.781
30 95,515 108,105 317,548
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Molecular Imaging | Antibody-based therapeutics | immunoPET | Targeted Radiotherapy | Cancer Biology |

25 19 0.760 36 29 0.806 1,590 1,181 0.743
Adscientificindex

A New and Different Feature!!!! University Subject Rankings in 12 subjects:

Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc.
31 98,307 111,292 328,505
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

24 23 0.958 58 48 0.828 1,852 1,560 0.842
32 102,250 115,722 344,077
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc

24 16 0.667 31 22 0.710 3,112 1,238 0.398
33 103,214 116,811 347,973
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Neuroscience

Neuroscience | Therapeutic antibodies |

24 13 0.542 27 17 0.630 2,747 1,439 0.524
34 106,027 119,994 358,959
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

Diabetes |

23 19 0.826 34 29 0.853 3,132 1,740 0.556
35 106,464 120,473 360,713
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Quantitative Clinical Pharmacology | Clinical Pharmacometrics | Statistics | Drug Development | Clinical |

23 18 0.783 42 33 0.786 2,009 1,289 0.642
36 106,941 121,005 362,350
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Biotherapeutic Protein/AAV Characterization | LC-MS/MS | Bottom-Up Proteomics | Target Proteomics |

23 18 0.783 27 23 0.852 2,600 1,353 0.520
37 111,272 125,884 379,663
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Molecular Biology & Genetics

Genome informatics |

22 20 0.909 28 26 0.929 10,158 6,192 0.610
38 112,035 126,732 382,388
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Chemical Sciences

Analytical Chemistry | LC-MS | CE-MS | Proteomics | Therapeutic protein |

22 19 0.864 29 25 0.862 1,601 895 0.559
39 112,272 126,986 382,969
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

Cancer Vaccines | Immunotherapy | Fibrosis | Myleoid cells | Aging | Renal and Cardiovascular Diseases | Lupus nephritis |

22 19 0.864 23 21 0.913 2,366 1,880 0.795
40 113,998 128,926 390,343
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Anti-cancer antibodies and cancer immunotherapy |

22 16 0.727 31 18 0.581 1,560 744 0.477
41 114,168 129,118 390,843
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

Neurobiology of learning and memory | context learning | coordinated neural processing | epilepsy | disease models |

22 16 0.727 27 23 0.852 1,916 1,270 0.663
42 116,690 131,956 400,696
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacology

cannabinoids | chronic pain | impulsivity | neuropsychopharmacology |

21 21 1.000 31 29 0.935 2,637 1,681 0.637
43 118,981 134,501 409,332
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Education / Education (Other, All)

Formulation Development | Process Development | Immunotherapeutics | Controlled Delivery |

21 18 0.857 30 25 0.833 1,352 860 0.636
44 119,634 135,232 411,966
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Others

21 17 0.810 33 22 0.667 2,211 1,454 0.658
45 119,717 135,329 412,367
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology | Pharmacokinetics | Drug-Drug Interactions | Biologics |

21 17 0.810 31 23 0.742 2,497 1,695 0.679
46 120,077 135,733 413,543
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Immunology

immunology | immune oncology |

21 17 0.810 25 19 0.760 4,911 2,509 0.511
47 121,324 137,156 419,038
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc

LNP | Antibody-Drug Conjugates | mAb Formulation | qMRI |

21 15 0.714 28 22 0.786 1,551 994 0.641
48 121,496 137,353 419,527
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc

CRISPR | cas9 | genome editing | genome engineering | targeted protein degradation |

21 15 0.714 24 18 0.750 2,021 1,033 0.511
49 122,813 138,843 425,305
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Diabetes | Obesity | Metabolism |

21 12 0.571 25 16 0.640 2,568 640 0.249
50 123,061 139,108 426,286
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Natural Sciences / Chemical Sciences

Mass Spectrometry | Bioanalysis | HDX | Biomarkers |

21 11 0.524 27 12 0.444 1,987 1,015 0.511